Yung E, Sorin M, Pal A, Craig E, Morozov A, Delattre O, Kappes J, Ott D, Kalpana G V
Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New York, USA.
Nat Med. 2001 Aug;7(8):920-6. doi: 10.1038/90959.
Integase interactor 1 (INI1), also known as hSNF5, is a protein that interacts with HIV-1 integrase. We report here that a cytoplasmically localized fragment of INI1 (S6; aa183-294) containing the minimal integrase-interaction domain potently inhibits HIV-1 particle production and replication. Mutations in S6 or integrase that disrupt integrase-INI1 interaction abrogated the inhibitory effect. An integrase-deficient HIV-1 transcomplemented with integrase fused to Vpr was not affected by S6. INI1 was specifically incorporated into virions and was required for efficient HIV-1 particle production. These results indicate that INI1 is required for late events in the viral life cycle, and that ectopic expression of S6 inhibits HIV-1 replication in a transdominant manner via its specific interaction with integrase within the context of Gag-Pol, providing a novel strategy to control HIV-1 replication.
整合酶相互作用蛋白1(INI1),也被称为hSNF5,是一种与HIV-1整合酶相互作用的蛋白质。我们在此报告,INI1的一个定位于细胞质的片段(S6;氨基酸183 - 294),包含最小的整合酶相互作用结构域,能有效抑制HIV-1病毒颗粒的产生和复制。S6或整合酶中破坏整合酶 - INI1相互作用的突变消除了这种抑制作用。用与Vpr融合的整合酶进行反式互补的整合酶缺陷型HIV-1不受S6影响。INI1被特异性地整合到病毒颗粒中,并且是高效产生HIV-1病毒颗粒所必需的。这些结果表明,INI1是病毒生命周期后期事件所必需的,并且S6的异位表达通过其在Gag-Pol背景下与整合酶的特异性相互作用以反式显性方式抑制HIV-1复制,为控制HIV-1复制提供了一种新策略。